Track topics on Twitter Track topics that are important to you
Julien Veys, chief business development officer at Theranexus, talks about the company's R&D strategy, which centers around new technologies to...
Theranexus debuts on Euronext Paris raising €19.6M that will support the development of its pipeline of CNS drugs for narcolepsy, Parkinson’s, Alzheimer’s and neuropathic pain. Theranexu...
FDA-approved labeling includes boxed warning for depression and suicidality, though this is specific for Huntington's disease patients, who are prone...
CD33 inhibiting drug that was yanked from the market in 2010 due to reports of veno-occlusive disease is now fully...
Tikomed CEO Adam Bruce talks to Scrip about the next steps for his company as it looks for partners to...
This week's roundup includes Almirall's appointment of a former Sanofi employee as CEO and various other high-level appointments by Axial...
At the 2017 BIO-Europe partnering meeting in Berlin, Germany, Ruediger Jankowsky managing director of Cinfa Biotech, talks about impending regulatory...
We have published hundreds of Theranexus news stories on BioPortfolio along with dozens of Theranexus Clinical Trials and PubMed Articles about Theranexus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Theranexus Companies in our database. You can also find out about relevant Theranexus Drugs and Medications on this site too.